Samuel Lunenfeld Research Institute, Mount Sinai Hospital

sinaihealth.ca

Total trials

133

Active

14

Phase 3

3

Total enrollment

10,459

Read this sponsor's pipeline like an analyst.

Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.

~15-30 sec · cached for 24h

Pipeline matrix

Showing 11 of 11 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
Oxytocin25
Carbetocin14
Phenylephrine5
Norepinephrine4
Ephedrine2
Ergonovine3
Carboprost3
Intrathecal Morphine2
Calcium2
Vasopressin1
Calcium Chloride1

Next readouts

  • 2026-06
  • 2026-12
  • 2026-12
  • 2026-12
  • 2026-12
  • 2026-12
  • 2026-12
  • 2026-12

Top conditions

  • Postpartum Hemorrhage29
  • Labor Pain21
  • Pain16
  • Pregnancy12
  • Hypotension7
  • Obesity4
  • Nausea3
  • Airway Complication of Anesthesia3

Frequently asked questions about Samuel Lunenfeld Research Institute, Mount Sinai Hospital

How many clinical trials does Samuel Lunenfeld Research Institute, Mount Sinai Hospital have on ClinicalTrials.gov?
Samuel Lunenfeld Research Institute, Mount Sinai Hospital is listed as the lead sponsor on 133 clinical trials in ClinicalTrials.gov, 14 of which are currently active (recruiting, enrolling, or ongoing).
How many of Samuel Lunenfeld Research Institute, Mount Sinai Hospital's trials are in Phase 3?
3 of Samuel Lunenfeld Research Institute, Mount Sinai Hospital's trials are in Phase 3, spread across 11 active drug programs.
What therapeutic areas does Samuel Lunenfeld Research Institute, Mount Sinai Hospital focus on?
Samuel Lunenfeld Research Institute, Mount Sinai Hospital's most-studied conditions on ClinicalTrials.gov are Postpartum Hemorrhage, Labor Pain, Pain, Pregnancy, Hypotension.
When are Samuel Lunenfeld Research Institute, Mount Sinai Hospital's next clinical trial readouts?
Samuel Lunenfeld Research Institute, Mount Sinai Hospital has 8 upcoming primary-completion readouts tracked here; the soonest is “Effect of Extracellular Calcium on Carbetocin Mediated Contractility in Human Myometrium”, expected around 2026-06.